Cingulate Therapeutics

1 follower

‌

Cingulate® is a biopharmaceutical company utilizing its innovative Precision Timed Release™ (PTR) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products.

Industries

Pharmaceutical

Headquarters

Kansas City, United States

Employees

11-50

Links

Org chart

Shane J. Schaffer

Chairman & CEO

Shane J. Schaffer

Collapse

Raul R. Silva

Chief Science Officer

Matthew Brams

Chief Medical Officer

Arthur Straughn

Co-founder Board of Directors

Jeff Bennett

Deputy General Counsel

Naama Courtemanche

Vp, Operations And Quality Assurance

Thomas Dalton

Vice President, Investor & Public Relations; Vice President, Government Affairs

Jennifer Callahan

Svp, Chief Financial Officer

Teams

Advisory Team

11 members

Leadership Team

3 members

Operations and Administration

4 members

Similar companies

Lenz Therapeutics

3 followers

Rocket Pharmaceuticals

2 followers

AVEO Oncology

2 followers

Organon

15 followers

Sitero

1 follower

SmithRx

4 followers

AbbVie

176 followers

Empower Pharmacy

3 followers

CONMED

2 followers

Crinetics Pharmaceuticals

1 follower

Amgen

211 followers

Explore companies